New QSAR Model for Predicting Blood Brain Barrier Permeability
May 8th 2023FDA’s Division of Applied Regulatory Science’s (DARS) computational toxicology and pharmacology research has been focused on the development of highly curated data sets and QSAR models for endpoints of regulatory interest.